These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 19448065)

  • 1. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
    Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N
    Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
    Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
    Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
    Nogi H; Suzuki M; Kamio M; Kato K; Kawase K; Toriumi Y; Takeyama H; Fukushima H; Morikawa T; Uchida K
    Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
    Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.
    Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M
    Breast J; 2008; 14(6):551-5. PubMed ID: 19000054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node.
    Beriwal S; Soran A; Kocer B; Wilson JW; Ahrendt GM; Johnson R
    Am J Clin Oncol; 2008 Feb; 31(1):34-8. PubMed ID: 18376225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
    Changsri C; Prakash S; Sandweiss L; Bose S
    Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.
    Rivers AK; Griffith KA; Hunt KK; Degnim AC; Sabel MS; Diehl KM; Cimmino VM; Chang AE; Lucas PC; Newman LA
    Ann Surg Oncol; 2006 Jan; 13(1):36-44. PubMed ID: 16378156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer.
    Ozmen V; Karanlik H; Cabioglu N; Igci A; Kecer M; Asoglu O; Tuzlali S; Mudun A
    Breast Cancer Res Treat; 2006 Jan; 95(1):1-6. PubMed ID: 16322900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
    Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact.
    Dabbs DJ; Fung M; Johnson R
    Breast J; 2004; 10(3):190-4. PubMed ID: 15125743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
    Port ER; Patil S; Stempel M; Morrow M; Cody HS
    Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.
    Saidi RF; Dudrick PS; Remine SG; Mittal VK
    Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of sentinel lymph node biopsy for the assessment of axillary status in patients with early (T1) breast carcinoma.
    Gurleyik G; Aker F; Sekmen U; Saglam A
    J Coll Physicians Surg Pak; 2005 Nov; 15(11):697-700. PubMed ID: 16300705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.